<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebrospinal Fluid (CSF) levels of the main metabolites of <z:chebi fb="0" ids="25375">monoamines</z:chebi> (MHPG, 5-HIAA, and HVA) were measured in patients with early <z:hpo ids='HP_0003674'>onset</z:hpo> (AD) and <z:hpo ids='HP_0003584'>late-onset</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>) <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD), and elderly controls </plain></SENT>
<SENT sid="1" pm="."><plain>Psychobehavioral assessment was carried out by means of MMSE and GBS </plain></SENT>
<SENT sid="2" pm="."><plain>Mean MHPG levels did not differ from controls; 5-HIAA was lower in VD when compared to both controls and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>HVA was decreased in AD, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>, and VD with respect to controls </plain></SENT>
<SENT sid="4" pm="."><plain>Significant correlations between HVA and psycho-behavioral parameters were observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> and VD groups, whereas no relationship was documented in AD </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> group was divided in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>-A (age at <z:hpo ids='HP_0003674'>onset</z:hpo>: greater than 65 less than or equal to 80 yr) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>-B (age at <z:hpo ids='HP_0003674'>onset</z:hpo>: greater than 80 yr) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>-A had significantly lower CSF HVA values than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>-B (165 +/- 64 vs 235.7 +/- 85) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>-B HVA levels were similar to those observed in controls </plain></SENT>
<SENT sid="8" pm="."><plain>Correlation analysis between HVA and neuropsychological variables was significant in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>-A, but not in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>-B </plain></SENT>
<SENT sid="9" pm="."><plain>These results might support the evidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
</text></document>